GENEVA, Sept. 7 -- AARVIK THERAPEUTICS, INC. filed a patent application (US2026/016918) for “B7H3/EPHA2 ANTIBODIES AND METHODS OF USE”. With publication no. WO/2026/183370, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: none
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....